The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pentavalent Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Pentavalent Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
This report is a detailed and comprehensive analysis for global Pentavalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pentavalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pentavalent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pentavalent Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd. and Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pentavalent Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lyophilized
Liquid
Market segment by Application
Retail Pharmacy
Hospital Pharmacy
E-commerce
Major players covered
Serum Institute of India
Panacea Drugs Pvt. Ltd
Shantha Biotechnics
Biological E. Ltd.
Novartis AG
Crucell
Bio Farma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pentavalent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pentavalent Vaccine, with price, sales, revenue and global market share of Pentavalent Vaccine from 2018 to 2023.
Chapter 3, the Pentavalent Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pentavalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pentavalent Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pentavalent Vaccine.
Chapter 14 and 15, to describe Pentavalent Vaccine sales channel, distributors, customers, research findings and conclusion.
The global Pentavalent Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
This report is a detailed and comprehensive analysis for global Pentavalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pentavalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pentavalent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pentavalent Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd. and Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pentavalent Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lyophilized
Liquid
Market segment by Application
Retail Pharmacy
Hospital Pharmacy
E-commerce
Major players covered
Serum Institute of India
Panacea Drugs Pvt. Ltd
Shantha Biotechnics
Biological E. Ltd.
Novartis AG
Crucell
Bio Farma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pentavalent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pentavalent Vaccine, with price, sales, revenue and global market share of Pentavalent Vaccine from 2018 to 2023.
Chapter 3, the Pentavalent Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pentavalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pentavalent Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pentavalent Vaccine.
Chapter 14 and 15, to describe Pentavalent Vaccine sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Pentavalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pentavalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lyophilized
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Pentavalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Retail Pharmacy
1.4.3 Hospital Pharmacy
1.4.4 E-commerce
1.5 Global Pentavalent Vaccine Market Size & Forecast
1.5.1 Global Pentavalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pentavalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global Pentavalent Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Serum Institute of India
2.1.1 Serum Institute of India Details
2.1.2 Serum Institute of India Major Business
2.1.3 Serum Institute of India Pentavalent Vaccine Product and Services
2.1.4 Serum Institute of India Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Serum Institute of India Recent Developments/Updates
2.2 Panacea Drugs Pvt. Ltd
2.2.1 Panacea Drugs Pvt. Ltd Details
2.2.2 Panacea Drugs Pvt. Ltd Major Business
2.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
2.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Panacea Drugs Pvt. Ltd Recent Developments/Updates
2.3 Shantha Biotechnics
2.3.1 Shantha Biotechnics Details
2.3.2 Shantha Biotechnics Major Business
2.3.3 Shantha Biotechnics Pentavalent Vaccine Product and Services
2.3.4 Shantha Biotechnics Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shantha Biotechnics Recent Developments/Updates
2.4 Biological E. Ltd.
2.4.1 Biological E. Ltd. Details
2.4.2 Biological E. Ltd. Major Business
2.4.3 Biological E. Ltd. Pentavalent Vaccine Product and Services
2.4.4 Biological E. Ltd. Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Biological E. Ltd. Recent Developments/Updates
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Pentavalent Vaccine Product and Services
2.5.4 Novartis AG Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis AG Recent Developments/Updates
2.6 Crucell
2.6.1 Crucell Details
2.6.2 Crucell Major Business
2.6.3 Crucell Pentavalent Vaccine Product and Services
2.6.4 Crucell Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Crucell Recent Developments/Updates
2.7 Bio Farma
2.7.1 Bio Farma Details
2.7.2 Bio Farma Major Business
2.7.3 Bio Farma Pentavalent Vaccine Product and Services
2.7.4 Bio Farma Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio Farma Recent Developments/Updates
3 Competitive Environment: Pentavalent Vaccine by Manufacturer
3.1 Global Pentavalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pentavalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Pentavalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pentavalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pentavalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Pentavalent Vaccine Manufacturer Market Share in 2022
3.5 Pentavalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pentavalent Vaccine Market: Region Footprint
3.5.2 Pentavalent Vaccine Market: Company Product Type Footprint
3.5.3 Pentavalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pentavalent Vaccine Market Size by Region
4.1.1 Global Pentavalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Pentavalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Pentavalent Vaccine Average Price by Region (2018-2029)
4.2 North America Pentavalent Vaccine Consumption Value (2018-2029)
4.3 Europe Pentavalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Pentavalent Vaccine Consumption Value (2018-2029)
4.5 South America Pentavalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Pentavalent Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pentavalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Pentavalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global Pentavalent Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pentavalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Pentavalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global Pentavalent Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Pentavalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Pentavalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Pentavalent Vaccine Market Size by Country
7.3.1 North America Pentavalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Pentavalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pentavalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Pentavalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Pentavalent Vaccine Market Size by Country
8.3.1 Europe Pentavalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Pentavalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pentavalent Vaccine Market Size by Region
9.3.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pentavalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Pentavalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Pentavalent Vaccine Market Size by Country
10.3.1 South America Pentavalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Pentavalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pentavalent Vaccine Market Size by Country
11.3.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pentavalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pentavalent Vaccine Market Drivers
12.2 Pentavalent Vaccine Market Restraints
12.3 Pentavalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pentavalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pentavalent Vaccine
13.3 Pentavalent Vaccine Production Process
13.4 Pentavalent Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pentavalent Vaccine Typical Distributors
14.3 Pentavalent Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
